Platinum nanoparticle antioxidants inhibit pulmonary inflammation in mice exposed to cigarette smoke
Platinum nanoparticle antioxidants inhibit pulmonary inflammation in mice exposed to cigarette smoke
复制标题
DOI:
10.1016/j.pupt.2008.12.015
复制
发表时间:
2009-08-01
影响因子:
3.2
通讯作者:
Nagai, Atsushi
中科院分区:
文献类型:
--
作者:
Onizawa, Shigemitsu;Aoshiba, Kazutetsu;Nagai, Atsushi
Recent evidence implicates increased oxidative stress as an important mechanism of the pulmonary inflammation that occurs in cigarette smokers. Since cigarette smoke (CS) contains and generates a large amount of reactive oxygen species (ROS) that elicit pulmonary inflammation, antioxidants may become effective therapeutic agents for CS-related inflammatory lung diseases, such as chronic obstructive pulmonary disease. Platinum nanoparticles stabilized with polyacrylate to form a stable colloid solution (PAA-Pt) are a new class of antioxidants that has been shown to efficiently quench ROS. In the present study we investigated the therapeutic effects of PAA-Pt on pulmonary inflammation in smoking mice. PAA-Pt or saline was administered intranasally to DBA/2 mice, which were then exposed to CS or control air daily for 3 days. Mice were sacrificed 4 h after their final exposure to CS or control air. CS exposure caused depletion of antioxidant capacity, NF kappa B activation, and neutrophilic inflammation in the lungs of mice, and intranasal administration of PAA-Pt prior to CS exposure was found to inhibit these changes. Intranasal administration of PAA-Pt alone did not elicit pulmonary inflammation or toxicity. In in vitro experiments, treatment of alveolar-type-II-like A549 cells with PAA-Pt inhibited cell death after exposure to a CS extract. These results suggest that platinum nanoparticles act as antioxidants that inhibit pulmonary inflammation induced by acute cigarette smoking. (C) 2008 Elsevier Ltd. All rights reserved.